Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer

European Journal of Surgical Oncology

Volumn 41, Issue 10, 2015, Pages 1308-1315

  Hirahara, N ^a   Matsubara, T ^a   Hayashi, H ^a   Takai, K ^a   Fujii, Y ^a   Tajima, Y ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Esophageal cancer; Glasgow Prognostic Score; Neutrophil lymphocyte ratio; Prognosis

Indexed keywords

AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; PRIORITY JOURNAL; RISK FACTOR; THORACOSCOPY; AGE; BLOOD; CARCINOMA, SQUAMOUS CELL; COHORT ANALYSIS; ESOPHAGEAL NEOPLASMS; IMMUNOLOGY; LEUKOCYTE COUNT; LYMPH NODE DISSECTION; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEUTROPHIL; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY;

C REACTIVE PROTEIN; CHOLESTEROL; SERUM ALBUMIN;

AGE FACTORS; AGED; C-REACTIVE PROTEIN; CARCINOMA, SQUAMOUS CELL; CHOLESTEROL; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LYMPH NODE EXCISION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEUTROPHILS; PROGNOSIS; RETROSPECTIVE STUDIES; SERUM ALBUMIN; THORACOSCOPY;

EID: 84943819245     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2015.07.008     Document Type: Article

References (33)

1. C.S. Roxburgh, and D.C. McMillan Role of systemic inflammatory response in predicting survival in patients with primary operable cancer Future Oncol 6 2010 149 163
2. D.B. Morgan, G.L. Hill, and L. Burkinshaw The assessment of weight loss from a single measurement of body weight: the problems and limitations Am J Clin Nutr 33 1980 2101 2105
3. M.L. Rowland Self-reported weight and height Am J Clin Nutr 52 1990 1125 1133
4. M. Ando, Y. Ando, Y. Hasegawa, and et al. Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer Br J Cancer 85 2001 1634 1639
5. G.J. Guthrie, K.A. Charles, C.S. Roxburgh, and et al. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer Crit Rev Oncol Hematol 88 2013 218 230
6. D.C. McMillan Systemic inflammation, nutritional status and survival in patients with cancer Curr Opin Clin Nutr Metab Care 12 2009 223 226
7. D.C. McMillan, M.M. Elahi, N. Sattar, and et al. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer Nutr Cancer 41 2001 64 69
8. T.P. Erlinger, E.A. Platz, N. Rifai, and et al. C-reactive protein and the risk of incident colorectal cancer JAMA 291 2004 585 590
9. P. Guillem, and J.P. Triboulet Elevated serum levels of C-reactive protein are indicative of a poor prognosis in patients with esophageal cancer Dis Esophagus 18 2005 146 150
10. L.M. Forrest, D.C. McMillan, C.S. McArdle, and et al. A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer Br J Cancer 92 2005 1834 1836
11. D.J. Brown, R. Milroy, R. Preston, and et al. The relationship between an inflammation based prognostic score (GPS) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer J Clin Pathol 60 2007 705 708
12. P. Glen, N.B. Jamieson, D.C. McMillan, and et al. Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer Pancreatology 6 2006 450 453
13. S. Ramsey, G.W. Lamb, M. Aitchison, and et al. Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer Cancer 109 2007 205 212
14. S.C. Kao, N. Pavlakis, R. Harvie, and et al. High blood neutrophil-tolymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy Clin Cancer Res 16 2010 5805 5813
15. B. Azab, V. Bhatt, J. Phookhan, and et al. Usefulness of the neutrophilto-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients Ann Surg Oncol 19 2012 217 224
16. L.M. Forrest, D.C. McMillan, C.S. McArdle, and et al. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer Br J Cancer 89 2003 1028 1030
17. L.H. Sobin, M.K. Gospodarowicz, and C. Wittekind TNM classification of malignant tumors 7th ed. 2010 Wiley-Blackwell Oxford
18. M.W. Saif, N. Makrilia, A. Zalonis, and et al. Gastric cancer in the elderly: an overview Eur J Surg Oncol 36 2010 709 717
19. L.M. Forrest, D.C. McMillan, C.S. McArdle, and et al. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer Br J Cancer 90 2004 1704 1706
20. H.S. Ahn, H.J. Lee, M.W. Yoo, and et al. Diagnostic accuracy of T and N stages with endoscopy, stomach protocol CT, and endoscopic ultrasonography in early gastric cancer J Surg Oncol 99 2009 20 27
21. H.H. Lee, C.H. Lim, J.M. Park, and et al. Low accuracy of endoscopic ultrasonography for detailed T staging in gastric cancer World J Surg Oncol 15 10 2012 190 10.1186/1477-7819-10-190
22. D.C. McMillan, W.S. Watson, P. O'Gorman, and et al. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss Nutr Cancer 39 2001 210 213
23. R. Al Shaiba, D.C. McMillan, W.J. Angerson, and et al. The relationship between hypoalbuminaemia, tumor volume and the systemic inflammatory response in patients with colorectal liver metastases Br J Cancer 91 2004 205 207
24. Y. Koike, C. Miki, Y. Okugawa, and et al. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer J Surg Oncol 98 2008 540 544
25. A.B. Crumley, R.C. Stuart, M. McKernan, and et al. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer J Gastroenterol Hepatol 23 2008 e325 329
26. M. Krzystek-Korpacka, M. Matusiewicz, D. Diakowska, and et al. Acute-phase response proteins are related to cachexia and accelerated angiogenesis in gastroesophageal cancers Clin Chem Lab Med 46 2008 359 364
27. K. Schumacher, W. Haensch, C. Roefzaad, and et al. Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas Cancer Res 61 2001 3932 3936
28. C. Gabay, and I. Kushner Acute-phase proteins and other systemic responses to inflammation N Engl J Med 340 1999 448 454
29. A.D. Gregory, and A.M. Houghton Tumor-associated neutrophils: new targets for cancer therapy Cancer Res 71 2011 2411 2416
30. M.J. Proctor, D.S. Morrison, D. Talwar, and et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study Eur J Cancer 47 2011 2633 2641
31. M.J. Proctor, D.C. McMillan, D.S. Morrison, and et al. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer Br J Cancer 107 2012 695 699
32. S.R. Walsh, E.J. Cook, F. Goulder, and et al. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer J Surg Oncol 91 2005 181 184
33. M.J. Proctor, P.G. Horgan, D. Talwar, and et al. Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study Cancer 119 2013 2325 2332